Stockholm, V7CIK 20031594 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
11 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Newmark Group Inc | 200.5K | $3.48M | 21.0% | +11.0K | Added |
| 2 | The Cigna Group | 11.8K | $3.25M | 19.7% | +11.8K | New |
| 3 | Arvinas Inc | 166.3K | $1.97M | 11.9% | +166.3K | New |
| 4 | Abivax SA |
| 14.4K |
| $1.94M |
| 11.7% |
| +14.4K |
| New |
| 5 | Iqvia Hldgs Inc | 8.2K | $1.84M | 11.1% | +8.2K | New |
| 6 | Maravai Lifesciences Hldgs I | 457.7K | $1.49M | 9.0% | +457.7K | New |
| 7 | Becton Dickinson & Co | 5.2K | $1.00M | 6.1% | +4.7K | Added |
| 8 | Atai Life Sciences NV | 234.9K | $960.8K | 5.8% | +234.9K | New |
| 9 | Soleno Therapeutics Inc | 8.7K | $404.7K | 2.4% | +8.7K | New |
| 10 | Klotho Neurosciences Inc | 606.8K | $175.4K | 1.1% | +606.8K | New |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio